rabab hegazy

Dr. rabab hegazy

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2025 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
RHrabab hegazy
rabab hegazy

28 August 2023 in Molecules
Verified
Journal Article
Open access
PDF file
MEMarwa A. Elsied
Marwa A. Elsied
ZSZeina Sharawi
Zeina Sharawi
HAHadba Al-Amrah
Hadba Al-Amrah
RHrabab hegazy
rabab hegazy
Amro El-Sherbeni MohamedAmro El-Sherbeni Mohamed
Amro El-Sherbeni Mohamed
Mohammed El-MagdMohammed El-Magd
Mohammed El-Magd
Decreased stemness and increased cellular senescence impair the ability of mesenchymal stem cells (MSCs) to renew themselves, change into different cell types, and contribute to regenerative medicine. There is an urgent need to discover new compounds that can boost MSCs’ stemness and delay senescence. Therefore, this study aimed to investigate the impact of walnut kernel oil (WKO) and defatted (WKD) extracts on bone marrow (BM)-MSC stemness and senescence. Premature senescence and inflammation were induced in BM-MSCs using H2O2 and LPS, respectively. Phytochemical constituents of WKO and WKD extracts were detected by HPLC. The stemness (proliferation and migration), senescence-related markers (p53, p21, SIRT1, and AMPK), oxidative stress/antioxidant markers, inflammatory cytokines, and cell cycle of BM-MSCs were measured by MTT assay, qPCR, ELISA, and flow cytometry. WKO and WKD extracts improved rat BM-MSC stemness, as evidenced by (1) increased cell viability, (2) decreased apoptosis (low levels of Bax and caspase3 and high levels of Bcl2), (3) upregulated MMP9 and downregulated TIMP1 expression, and (4) cell cycle arrest in the G0/G1 phase and declined cell number in the S and G2/M phases. Additionally, WKO and WKD extracts reduced rat BM-MSC senescence, as indicated by (1) decreased p53 and p21 expression, (2) upregulated expression and levels of SIRT1 and AMPK, (3) reduced levels of ROS and improved antioxidant activity (higher activity of CAT, SOD, and GPx and upregulated expression of NrF2 and HO-1), and (4) declined levels of TNFα, IL1β, and NF-κB. When compared to the WKO extract, the WKD extract had a greater impact on the induction of stemness and reduction of senescence of BM-MSCs due to its stronger antioxidant activity, which could be attributed to its higher levels of flavonoids and phenolic compounds, as detected by HPLC analysis. WKO and WKD extracts enhance rat BM-MSC stemness and protect them from senescence, suggesting their potential use as enhancers to increase MSCs’ therapeutic efficacy.

3 June 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
ZSZeina Sharawi
Zeina Sharawi
SAShimaa Ali Abass
Shimaa Ali Abass
MZManal A. Zubair
Manal A. Zubair
RHrabab hegazy
rabab hegazy
FFFoad Farrag
Foad Farrag
AEAbdullah Elgazar
Abdullah Elgazar
Background/Objectives: The present study aimed to evaluate the nephroprotective role of Khellin (Khe) against cisplatin (CDDP)-mediated nephrotoxicity in rats. Methods: We assessed oxidative stress markers (MDA, CAT, SOD, GPx, and iNOs), inflammatory markers (TNFα, IL6, IL10, and MCP1), apoptotic markers (Bax and Bcl2), and the renal damage marker (Kim1). Network pharmacology and molecular docking studies were performed. In vitro, Khe effects were tested on normal kidney cells (Vero) and liver cancer cells (HepG2) treated with CDDP. Results: Network pharmacology and docking suggested Khe’s activity primarily affects oxidative stress and inflammatory pathways, notably through MAPK14 and PI3K downregulation. In vitro, Khe reduced CDDP’s cytotoxicity in Vero cells while maintaining anti-proliferative effects on HepG2 cells. In vivo, CDDP significantly increased serum creatinine, urea, Kim1, oxidative stress markers (MDA and iNOS), and inflammatory markers (TNFα, IL6, and MCP1) while decreasing antioxidant markers (SOD, GPx, CAT, and SOD3) and anti-inflammatory cytokine (IL10) levels. Khe treatment dose-dependently attenuated these changes, with the 100 mg/kg dose showing the most significant renoprotection. Histopathological analysis confirmed improved renal tissue integrity in Khe-treated groups. Conclusions: This study demonstrates that Khe exerts significant nephroprotective effects against CDDP-induced nephrotoxicity by mitigating oxidative stress, inflammation, and apoptosis while improving renal function and structure. These findings suggest Khe as a promising therapeutic candidate for preventing CDDP-related kidney injury.

18 April 2025 in Journal of Radiation Research and Applied Sciences
Verified
Journal Article
Open access
RHrabab hegazy
rabab hegazy
AAAmal A. Abdulbaqi
Amal A. Abdulbaqi
RHRym Hassani
Rym Hassani
SESanad S. El-Kholy
Sanad S. El-Kholy
FFFoad Farrag
Foad Farrag
Mohammed El-MagdMohammed El-Magd
Mohammed El-Magd

1 April 2025 in Journal of Radiation Research and Applied Sciences
Verified
Journal Article
Open access
YLYanyan Li
Yanyan Li
RDRongwu Ding
Rongwu Ding
YLYueqiong Liu
Yueqiong Liu
YZYi Zhang
Yi Zhang
Heba GhamryHeba Ghamry
Heba Ghamry
Mohammed El-MagdMohammed El-Magd
Mohammed El-Magd

1 June 2024 in Journal of Bioscience and Applied Research
Verified
Journal Article
Open access
PDF file
NENabila El-Desouki
Nabila El-Desouki
MBMohamed Basyony
Mohamed Basyony
SOSoha Okba
Soha Okba
RHrabab hegazy
rabab hegazy
BAButhina Alshammari.
Buthina Alshammari.
Aim: evaluate the impact of milk thistle (Silybum marianum) on CD34 and vimentin expression in hepatic fibrosis and cirrhosis induced with CCl4 in experimental mice. Methods: GI: normal group given no therapy; control group. GII: received a daily dose (1mL/kg/bw/d) of milk thistle oil M.T.O for 4 weeks; GIII&GIV: injected i.p. with (1:1 ratio) mixture of CCl4 and olive oil (1mL/kg/bw) twice weekly for 4 weeks to induce fibrosis, and for 6 weeks to induce cirrhosis. Gp5 and Gp6: fibrotic and cirrhotic groups administered M.T.O as in Gp2. The results showed that liver sections of Gp1 and Gp2 showed normal moderate to strong CD34 expression in the endothelial cells of the blood sinusoids and many hepatocytes. The liver tissues of Gp3 and Gp4 expressed decrement CD34 immunoreactivity in many hepatic lobules. The liver sections of Gp5 or Gp6 showed restoration of CD34 expression in most of the hepatic tissues. In Gp1 and Gp2, the vimentin was expressed as weak or moderate immunostaining in the endothelial cells and connective tissues (wall of the blood sinusoids, central portal veins, and portal tract stroma). The liver sections of Gp3 and Gp4 showed overexpression of vimentin immunoreactivity. The treatment with M.T.O in Gp5 and Gp6 showed improvement and recovery of vimentin expression in the hepatic lobules. Conclusion: M.T.O. treatment improved the hepatic injury induced in fibrotic or cirrhotic tissues by CCl4 injection and could be recommended for patients with fibrotic and cirrhotic liver diseases.